Search Results
Apr 23, 2026, 09:53 ET Backroads Unveils New 2027 Adventures from the Faroe Islands to Zanzibar
Romania Hiking & Walking TourA true hiker's adventure, offering a rare mix of rugged wilderness, rich culture and fascinating history from the Carpathian Mountains and Transylvania to the capital of Bucharest. (Activity
More news about: Backroads
Apr 23, 2026, 09:30 ET 5WPR and Talent Resources Release New Research: The Celebrity-Brand Fit Index
Bieber's rhode sale to e.l.f. Beauty for up to $1 billion in 2025, SKIMS at a $5 billion valuation after Goldman Sachs' November 2025 investment, and Rare Beauty at an estimated $2.7 billion.Hospitality and Travel (7.6) scores third, with case studies across restaurants, hotels, branded
More news about: 5W Public Relations
Apr 23, 2026, 09:00 ET SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Drug Safety Risks: SueWallSt
Affected DCCR's Commercial ProfileDCCR was the first FDA-approved treatment for hyperphagia in individuals with Prader-Willi syndrome, a rare genetic condition affecting an estimated 300,000 to 400,000 individuals worldwide. The drug was priced at approximately $500,000 per year per patient,
More news about: SueWallSt.com
Apr 23, 2026, 09:00 ET Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex
dystrophy ("DMD"). This rare, fatal genetic neuromuscular disease results in deterioration of the skeletal, heart and lung muscles. Interactions with the FDA are underway regarding the study results and remaining requirements for approval. The program has received Orphan Drug, Rare Pediatric Disease and
More news about: Cumberland Pharmaceuticals Inc.
Apr 23, 2026, 09:00 ET Decera Clinical Appoints Industry Veteran Guy Slatcher, Ph.D., as President of Medical Communications
Chameleon Communications (Omnicom Health), where he served as U.S. President."As medical communications continue to evolve at pace, Guy brings the rare combination of scientific depth, global leadership experience, and strategic clarity required to lead in this environment," said Leo Tarkovsky, Chief
More news about: Decera Clinical
Apr 23, 2026, 09:00 ET ODD Lawsuit Alleges Material Omissions Regarding Advertising Cost Disruptions - ODDITY TECH LTD. Investors Face Losses Following the Revelation of Financial Model Erosion: SueWallSt
NEW YORK, April 23, 2026 /PRNewswire/ -- ODDITY Tech Ltd.'s SEC filings touted a "powerful and rare combination of scale, growth, and profitability" while allegedly omitting specific, known disruptions to the Company's advertising cost
More news about: SueWallSt.com
Apr 23, 2026, 09:00 ET CompuCycle and Pearland ISD Launch TechCycle: A Workforce Training Program Giving Students with Disabilities a Real Path to Employment
self-supporting model designed to be replicated across Texas school districts.For many of the students in the program, TechCycle offers something rare: work they can own. Instructors report that students on the autism spectrum have thrived in the structured, step-by-step environment. Within weeks of
More news about: CompuCycle
Apr 23, 2026, 09:00 ET NEURELIS HELPS SUPPORT NATIONAL NETWORK OF EPILEPSY AWARENESS AND SUPPORT AT FIRST EPILEPSY AWARENESS DAY AND EDUCATION EXPO AT WALT DISNEY WORLD
BA-1049), an investigational, Phase 1 new chemical entity Rho kinase (ROCK) inhibitor, for the treatment of cerebral cavernous malformations (CCMS), a rare disorder of the central nervous system (CNS). For more information on Neurelis, please visit
More news about: Neurelis, Inc.
Apr 23, 2026, 08:43 ET Pickleball Kingdom Accelerates Expansion in California with Multi-Unit Bay Area Deal
Atul represent the gold standard of franchise partnership," said Rob Streett, President and Chief Global Officer of Pickleball Kingdom. "They bring a rare combination of sophisticated business acumen with a deep-rooted passion for community building. Their investment is a powerful endorsement of our vision
More news about: Pickleball Kingdom Franchising
Apr 23, 2026, 08:30 ET Servier completes the acquisition of Day One Biopharmaceuticals
in pediatric low-grade glioma. Transaction also includes a strong oncology pipeline of clinical stage assets in rare cancers with high unmet needs. Transaction represents total equity value of approximately $2.5 billion.SURESNES,
More news about: Servier
Apr 23, 2026, 08:30 ET Servier completes the acquisition of Day One Biopharmaceuticals
in pediatric low-grade glioma. Transaction also includes a strong oncology pipeline of clinical stage assets in rare cancers with high unmet needs. Transaction represents total equity value of approximately $2.5 billion.SURESNES,
More news about: Servier
Apr 23, 2026, 08:16 ET Speed, Expertise and Advanced Technology Combine to Save an Infant's Heart
heart to "break" the arrhythmia and restore normal rhythm.The problem: nearly all these devices are designed for adult-sized bodies. Even in the rare cases when children need them, the patient generally needs to weigh at least 70 pounds. Some externally wearable defibrillators exist for smaller children,
More news about: Cincinnati Children's Hospital Medical Center
Apr 23, 2026, 08:15 ET Kennedy Funding Closes $4.4M Land Loan in Spicewood, Texas
with utilities already brought to the site. With no current zoning requirements, the land offers flexibility for future development — an increasingly rare advantage in a market experiencing rapid expansion."This was a pure cash-out refinance," said CEO and President, Kevin Wolfer. "The owner had
More news about: Kennedy Funding
Apr 23, 2026, 08:00 ET Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
Kinase AMP-activated non-catalytic subunit Gamma 2) syndrome and ATR 1086 for PLN (phospholamban) cardiomyopathy, and two undisclosed research targets in rare cardiomyopathies.For more information about our RNA delivery platform, development pipeline and people, please visit
More news about: Atrium Therapeutics
Apr 23, 2026, 07:00 ET TrendAI™'s AI Security Brief podcast joins the N2K CyberWire network.
organizations work to understand AI's real-world implications and opportunities," said Peter Kilpe, Chief Executive Officer of N2K Networks. "TrendAI™ brings a rare combination of deep vulnerability research and operational leadership expertise, ensuring that the security leaders and operators in our audience stay
More news about: N2K Networks
Apr 23, 2026, 06:40 ET Energy Fuels Announces Call Details for Q1-2026 Earnings
April 23, 2026 /PRNewswire/ - Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), a leading U.S. producer of uranium, rare earth elements, and critical materials, will hold a conference call on Thursday, May 7, 2026, at 9:00 AM Mountain Time to discuss its financial results
More news about: Energy Fuels Inc.
Apr 23, 2026, 06:30 ET Lockheed Martin Reports First Quarter 2026 Financial Results
programs, compliance with stringent performance and reliability standards, and materials availability, including government furnished equipment and rare earth minerals;the timing of contract awards or contract definitization, decisions by government customers to impose contract terms following
More news about: Lockheed Martin
Apr 23, 2026, 04:00 ET REALM Global Network Brings Together Top Real Estate Advisors and Futurists to Chart the Future of Luxury Real Estate
Over four days, the Collective delivered something rare in the real estate industry: an intellectually rigorous, emotionally resonant, and deeply honest examination of where luxury real estate is going—and
More news about: REALM
Apr 23, 2026, 02:34 ET DUAL-PATHWAY BLOCKADE THERAPY OFFERS HOPE FOR RARE, HARD-TO-TREAT GYNAECOLOGICAL CLEAR CELL CANCERS
it is all about the patients. Trials like ours are small but mean a lot for patients with rare cancer subtypes who are often excluded from larger randomised trials that focus on the common cancer subtypes. Rare cancers like clear cell gynaecological cancers are an area of urgent unmet clinical need where
More news about: National University Cancer Institute, Singapore (NCIS)
Apr 23, 2026, 02:00 ET PrecisionBiotics® (Novonesis) and Biocodex Mark Next Phase of Strategic Partnership with New Agreement
French pharmaceutical company present in over 100 countries. As a pioneer in microbiota research, it offers innovative solutions in women's health, rare diseases, and established products for common health needs for a more human, accessible, and sustainable approach to health.
More news about: PrecisionBiotics®, part of Novonesis
Apr 22, 2026, 16:35 ET Viking Therapeutics to Report Financial Results for First Quarter 2026 on April 29, 2026
of internally developed dual amylin and calcitonin receptor agonists (or DACRAs) for the treatment of obesity and other metabolic disorders. In the rare disease space, Viking is developing VK0214, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the potential
More news about: Viking Therapeutics, Inc.
Apr 22, 2026, 16:05 ET Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Showing Sustained Glucocorticoid Dose Reductions While Maintaining Androgen Control in Adults with Classic Congenital Adrenal Hyperplasia
Treatment: 1-Year Results from CAHtalyst AdultAbout Congenital Adrenal Hyperplasia Congenital adrenal hyperplasia (CAH) is a rare genetic condition that results in an enzyme deficiency that alters the production of adrenal steroid hormones, such as cortisol, aldosterone and adrenal
More news about: Neurocrine Biosciences, Inc.
Apr 22, 2026, 16:00 ET AMGEN ANNOUNCES RETIREMENT OF DAVID M. REESE, EXECUTIVE VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICER
health, Burton remains focused on reaching clinicians and patients with medicines and solutions in areas of greatest unmet need, from cardiovascular to rare diseases.Together, these changes deepen the integration of science and technology and align the organization with the evolving adoption
More news about: Amgen
Apr 22, 2026, 14:55 ET KIMPTON ASHBEL NEW YORK - PARK AVENUE OPENS IN HISTORIC MIDTOWN MANHATTAN LANDMARK
adds: "Kimpton Ashbel is a haven for travelers who view luxury not by extravagance, but by the comfort of belonging, the beauty of serenity and the rare feeling of knowing the city before smartphones. Our location is special, for the city, our guests, and Kimpton. It was here that Kimpton was first introduced
More news about: Kimpton Ashbel New York - Park Avenue
Apr 22, 2026, 14:08 ET Farm4Profit Media Caps Landmark Winter Tour with Record-Breaking Shows, Major Equipment Launches, and a Sit-Down with USDA Undersecretary Richard Fordyce
centerpiece of the Commodity Classic coverage was Farm4Profit's interview with Richard Fordyce, USDA Undersecretary for Farm Production and Conservation, a rare opportunity to bring national ag policy directly to the podcast's farmer audience."Commodity Classic is where agriculture's biggest conversations
More news about: Farm4Profit Media